We maintain an OUTPERFORM rating on SSI but cut our target price by 22% as we (1) cut our net income forecasts for 2020/21/22 by 3.7%/5.9%/6.4%, (2) change our sum-of-the-parts valuation to the equity DCF approach and (3) cut our target 2020F P/B to 1.0x